Skip to content

Investigating attention in people with asthma

Investigating maladaptive cognitive biases in patients with asthma using a bronchial hyperreactivity challenge.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN55124010
Enrollment
40
Registered
2016-04-29
Start date
2016-04-30
Completion date
Unknown
Last updated
2017-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma Respiratory

Interventions

Participants will complete some baseline measures of lung function and psychological measures. They will then complete the key outcome measures (computer tasks, and anxiety-related questionnaires) DUR

Sponsors

University of Southampton
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Adult (over 18 years) 2. Confirmed diagnosis of asthma. Asthma severity will be clinically diagnosed according to BTS guidelines from Step 1 [mild intermittent asthma] to Step 4 [persistent poor control], have an FEV1 of 60% or more in order to undergo methacholine challenge

Exclusion criteria

Exclusion criteria: 1. Patients under 18 years of age 2. Comorbid psychological disorders other than anxiety/depression (measured using the MINI 3. neuropsychiatric interview questionnaire) 4. Currently participating in an active asthma intervention study 5. Have had acute exacerbation of asthma (needing a course of oral steroid of increased dose of maintenance steroid) with 28 days of the first intervention study Asthma severity is characterised according to BTS guidelines as Step 5 (continuous or frequent use of oral steroids)

Design outcomes

Primary

MeasureTime frame
1. Attentional functioning, measured using the computerized Attention network test 2. Attention biases towards threatening stimuli, measured using a dot-probe task 3. Severity of anxiety, measured using the spielberger state-trait anxiety inventory Measured during vs. after methacholine challenge

Secondary

MeasureTime frame
1. Mindfulness and attention questionnaires, measured using the MAAS and ACS 2. Asthma control/quality of life, measured using the ACQ and AQLQ Measured at baseline

Countries

United Kingdom

Contacts

Public ContactMegan Liddiard

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026